Oncternal Therapeutics (ONCT) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-3.11
-2.12
-1.13
-0.14

Details

Expected EPS
-2.8775
Actual EPS
-2.83
Surprise EPS
0.05
Surprise Percent
+1.65%

Description

Oncternal Therapeutics (ONCT) has reported earnings of -2.83 per share for Q2 2024.

0 Comments

Share your thoughts